Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart Disease

NCT02448524 is registered in ClinicalTrials.gov with Micell Technologies as lead sponsor.

NCT NCT02448524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02448524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-blinded, Multi-center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart Disease
Lead sponsor
Micell Technologies
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2015
Completion date
November 30, 2022
Enrollment
428 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease